FIGURE 4.

Evidence‐based hierarchical classification of TP53‐mutated (TP53 mut) myeloid neoplasms (MN). AML—acute myeloid leukemia; CK—complex karyotype; EB—excess blasts; LB—low (< 5% blasts); MDS—myelodysplastic syndrome; OS—overall survival (calculated from diagnosis); VAF—variant allele frequency. Adapted from Shah et al. (Blood Adv, in print).